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BRIEF DEFINITIVE REPORT
            Diff  erentiation of the new CD4 eff  ector subset 
Th17 requires the presence of IL-6 and TGF-     
and is further enhanced by IL-1     and -21 (  1, 2  ). 
In addition, Th17 polarization is promoted by 
stimulation of the aryl hydrocarbon receptor 
(AhR) (  3  ), a ligand-dependent transcription 
factor that responds to a wide range of ligands. 
Ligands include environmental toxins, such as 
halogenated aromatic hydrocarbons represented 
by tetrachlorodibenzo-  p  -dioxin (TCDD) and 
polycyclic aromatic hydrocarbons (e.g., 3-meth-
ylcholanthrene), as well as potential endogenous 
ligands, including dietary components, heme 
metabolites, indigoids, and tryptophan metabo-
lites ( 4  ). The tryptophan metabolite 6-formylin-
dolo[3,2-b] carbazole (FICZ) was shown to 
have very high affi   nity for AhR, comparable to 
that of TCDD (  5  –  7  ). Exposure of CD4 T cells 
to FICZ under Th17-polarizing conditions en-
hances Th17 development and functions such 
as autoimmune pathology in EAE, which is 
substantially exacerbated by AhR ligation, and 
it induces expression of IL-22 (  3  ). Despite the 
fact that AhR binds many toxins, its evolution-
ary conservation (  8  ) suggests that this is not its 
primary function. Although invertebrate AhR 
shares high protein sequence homology with 
the vertebrate receptor, it does not recognize 
xenobiotic ligands such as TCDD or     -naph-
thofl  avone, which indicates that the AhR has 
physiological functions that are not restricted to 
recognition of environmental pollutants (  5  ). 
  Involvement of an endogenous AhR ligand 
in Th17 development in vivo is suggested by the 
fact that AhR-defi  cient mice have an attenuated 
Th17 program, with fewer Th17 cells acti-
vated upon immunization with MOG peptide/
CFA, resulting in milder pathology in the EAE 
model and the absence of IL-22 production (  3  ). 
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  Th17 cell differentiation is dependent on interleukin (IL)-6 and transforming growth factor 
(TGF)-    , and it is modulated by activation of the aryl hydrocarbon receptor (AhR). In this 
study, we show that differentiation of Th17 cells, but not Th1 or induced regulatory T 
(iT reg) cells, is increased by endogenous AhR agonists present in culture medium. Th17 devel-
opment from wild-type mice is suboptimal in the presence of the AhR antagonist CH-
223191, similar to the situation in AhR-defi  cient mice, which show attenuated IL-17 
production and no IL-22 production. The presence of natural AhR agonists in culture 
medium is also revealed by the induction of CYP1A1, a downstream target of AhR activa-
tion. However, the most commonly used medium, RPMI, supports very low levels of Th17 
polarization, whereas Iscove  ’  s modifi  ed Dulbecco  ’  s medium, a medium richer in aromatic 
amino acids, which give rise to AhR agonists, consistently results in higher Th17 expansion 
in both mouse and human cells. The relative paucity of AhR agonists in RPMI medium, 
coupled with the presence of factors conducive to IL-2 activation and enhanced Stat5 
phosphorylation, conspire against optimal Th17 differentiation. Our data emphasize that 
AhR activation plays an essential part in the development of Th17 cells and provide a 
rational explanation for the poor in vitro polarization of Th17 cells that is reported in the 
majority of publications for both mouse and human cells. 
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tions show increased Stat5 phosphorylation. Given that IL-2 
dampens Th17 diff  erentiation via the induction of Stat5 (  10  ), 
it is not surprising that Th17 diff  erentiation is diffi   cult to ob-
tain in this medium. Our results emphasize the important 
role AhR agonists play in the modulation of the Th17 pro-
gram and illustrate that diff  erentiation of this eff  ector T cell 
subset is inhibited by factors that are conducive to generation 
of the other T cell subsets, a fact that is refl  ected in the for-
mulation of some culture media that support Th1, Th2, and 
regulatory T (T reg) cell diff  erentiation, but lead to ineffi   -
cient Th17 development. 
    RESULTS AND DISCUSSION   
  AhR antagonist CH-223191 impairs Th17 differentiation 
  Because tryptophan metabolites generated by light exposure, 
such as FICZ, are potent enhancers of Th17 diff  erentiation and 
there are reports suggesting that light exposure of culture me-
dium generates AhR ligands that contribute to background 
AhR activation (  11  ), we set out to assess Th17 development 
from naive precursors in the absence or presence of an AhR an-
tagonist. Several AhR antagonists found in food components, 
such as fl  avones and resveratrol have been previously described 
(  12  ), but all of them seem to exert AhR agonist activity at high 
concentrations (  13  ). In contrast, screening of a chemical library 
The attenuated Th17 development from naive CD4 T cell 
precursors of AhR-defi  cient mice is also noticeable in vitro. 
  There are several studies in the toxicology fi  eld suggest-
ing that high affi   nity ligands for AhR are generated in culture 
medium and play a role in the baseline activation of AhR in 
hepatocyte cell lines, resulting in activation of genes encod-
ing xenobiotic metabolizing cytochrome P450 enzymes such 
as CYP1A (for review see reference [  9  ]). These findings 
prompted us to test whether such endogenous AhR activity 
might infl  uence the diff  erentiation of Th17 eff  ector cells in 
vitro. Indeed, our studies show that addition of an AhR an-
tagonist during Th17 polarization decreases Th17 polariza-
tion, whereas it does not infl  uence diff  erentiation of other 
eff  ector T cell subsets. Interestingly, we also found that there 
are substantial diff  erences in regard to generation of endoge-
nous AhR ligands in diff  erent culture media, with RPMI 
having far less activity than IMDM. This could explain the 
puzzling variability in the literature in regard to Th17 polar-
ization, which is generally in the range of 5  –  20%, whereas 
our values usually range from 40  –  60%. RPMI is by far the 
most commonly used culture medium, but as we show here, 
IMDM supports better Th17 polarization from both mouse 
and human CD4 T cells. We also observed that in RPMI, 
but not IMDM, CD4 T cells cultured under Th17 condi-
    Figure 1.         Increased Th17 polarization caused by endogenous AhR ligands.   (A) Intracellular staining for IL-17 versus IL-22 of CD4 T cells from con-
trol B6 (top) or AhR-defi  cient (bottom) cells polarized under Th17 conditions in IMDM for 5 d in the absence (left) or presence (right) of AhR antagonist 
CH-223191. Representative dot plots of four independent experiments are shown. (B) Intracellular staining for IL-17A versus IFN-     or IL-17A versus 
Foxp3 of CD4 T cells from B6 mice cultured under Th1 conditions (top) or iT reg cell conditions (bottom) in the absence (left) or presence (right) of AhR 
antagonist CH-223191. Dot plots are representative of three independent experiments. (C) qPCR kinetic analysis of AhR, IL-17, IL-22, and CYP1A1 expres-
sion after activation of naive CD4 T cells under Th17 conditions. Expression in CD4 T cells activated under neutral conditions is shown for comparison. The 
fi  gure shows mRNA levels normalized to   Hprt   expression and is representative of three independent experiments.     JEM VOL. 206, January 19, 2009  45
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identifi  ed CH-223191 as an antagonist that lacked agonist activ-
ity even at high doses (  14  ). Th17 diff  erentiation of naive CD4 T 
cells from B6 mice was markedly inhibited in the presence of the 
AhR antagonist (  Fig. 1 A,   left).   CD4 T cells from AhR-defi  -
cient mice showed attenuated Th17 development, as previously 
described (  3  ), and this was not infl  uenced by the presence of 
AhR antagonist (  Fig. 1 A,   right). IL-22 expression is low, but 
detectable, in Th17 cells from wild-type B6 mice, but abrogated 
in the presence of AhR antagonist and absent in Th17 cells from 
AhR-defi  cient mice. 
  In contrast to Th17 cells, the generation of Th1 or induced 
T reg (iT reg) eff  ector cells was not inhibited in the presence 
of AhR antagonist (  Fig. 1 B  ), which is in line with our fi  nding 
that they do not express AhR (  3  ). It has been suggested that 
AhR ligation by TCDD, a high affi   nity, nonmetabolized AhR 
ligand, induces regulatory T cells (  15, 16  ). However, it re-
mains to be investigated whether the AhR ligand directly af-
fected regulatory T cells, as so far only changes in percentage 
of T reg cells were measured under conditions in which other 
T cell subsets, such as Th17, underwent apoptosis; this would 
result in a proportional shift toward T reg cells, especially if 
these cells are not aff  ected by AhR ligands. The presence of 
endogenous AhR agonists in culture medium was additionally 
supported by kinetic analysis of the expression of AhR and 
CYP1A1, which is an AhR-dependent enzyme whose ex-
pression is induced upon AhR activation. Under Th17 condi-
tions, AhR expression was induced     12 h after the onset of 
culture and, concordantly, induction of CYP1A1 expression was 
observed, followed by expression of IL-17 and -22 (  Fig. 1 C  ). 
It should be emphasized that because we culture highly FACS-
purifi  ed naive CD4 T cells without the presence of APCs, 
there is no source of IL-23 in these cultures, so the induction 
of IL-22 is independent of this cytokine. 
  Thus, our results indicate that there are endogenous AhR 
agonists in culture medium, resulting in AhR activation, 
which plays an important role in shaping Th17 polarization, 
whereas it does not play a role for Th1 or iT reg cells. The 
molecular mechanisms involved in AhR modulation of the 
Th17 program are currently not well defi  ned. Our recent 
data indicated that AhR expression on its own does not drive 
expression of IL-17 or -22 (  3  ). Furthermore, forced expres-
sion of either ROR    t or AhR does not impact on the ex-
pression of the other transcription factor (  Fig. 2 A  ).   Even 
cotransduction of both transcription factors is insuffi   cient to 
aff  ect the characteristic Th17 modulation with IL-22 induc-
tion (  Fig. 2 B  ), suggesting that other pathways are involved. 
Thus, it was recently suggested that AhR interacts with Stat1 
and Stat5 and that it may regulate Th17 development by 
modifying the activation of these two negative regulators of 
Th17 generation (  17  ). 
  Reduced endogenous AhR ligands in RPMI medium 
  We noticed in the course of experiments on Th17 polarization 
that diff  erent individuals consistently obtained diff  erent levels of 
Th17 polarization, despite our using the same pool of FACS-
sorted naive CD4 T cells as a starting population. Eventually, it 
    Figure 2.         Independent ROR    t and AhR regulation in Th17 cells  .    
(A) FACS-sorted naive CD4 T cells retrovirally transduced with RV-GFP 
control, AhR-GFP, or ROR    t-GFP vector as indicated on abscissa were 
cultured in the presence (shaded bars) or absence (open bars) of FICZ. As a 
comparison, FACS-sorted naive CD4 T cells cultured under Th17 condition 
in the presence (shaded bars) or absence (open bars) of FICZ are shown. 
The fi  gure shows mRNA expression for the indicated genes normalized for 
HPRT mRNA expression. The fi  gure is representative of three independent 
experiments. (B) FACS-sorted naive CD4 T cells were retrovirally trans-
duced with either control vector containing truncated human CD4 
(RV-hCD4    cyto) together with RV-GFP control vector (top) or with 
Ahr-hCD4    cyto together with ROR    t-GFP (bottom) and cultured in the 
presence of FICZ. Expression of hCD4 versus GFP is shown on the left. 
Intracellular IL-22 expression in gated populations is shown on the right. 
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tenuated Th17 polarization irrespective of the source of cul-
ture medium (  Fig. 3 A  ).   The AhR antagonist CH-223191 
strongly reduced Th17 development from B6 CD4 T cells in 
became clear that some researchers used RPMI as culture me-
dium, like most immunological laboratories, whereas IMDM, a 
richer culture medium developed by Norman Iscove at the Basel 
Institute for Immunology (  18  ), was typically used by former Ba-
sel Institute researchers and was the medium used in the original 
studies showing that TGF-     and IL-6 drive Th17 diff  erentiation 
(  19  ). It is noteworthy that IMDM contains three- to fi  vefold 
higher amounts of aromatic amino acids, such as tryptophan, 
tyrosine, and phenylalanine (Table S1, available at http://www
.jem.org/cgi/content/full/jem.20081438/DC1), than RPMI 
medium, which could give rise to diff  erent levels of endogenous 
AhR ligands in the two types of media. 
  Th17 diff  erentiation in RPMI medium was consistently 
lower and similar to that of AhR-defi  cient cells that show at-
    Figure 3.         Suboptimal Th17 differentiation in RPMI medium.  
(A) Scatter plots showing the percentage of IL-17 polarization from indi-
vidual experiments with CD4 T cells from B6 (fi  lled triangles) or AhR-
defi  cient mice (open circles) cultured under Th17-polarizing conditions in 
IMDM or RPMI in the presence or absence of AhR antagonist (left). 
P value control versus AhR antagonist for B6 are   <  0.001; between IMDM 
and RPMI B6 control values P   <   0.001. Data from four independent ex-
periments are shown. (right) Percentage of IFN-     producers  (fi  lled dia-
monds) or Foxp3 expression (open squares) in B6 CD4 T cells cultured 
under Th1 or iT reg cell conditions, respectively in IMDM or RPMI. P value 
for iT reg cell generation in IMDM versus RPMI is P   <   0.01. (B) Total CD4 
T cells purifi  ed from PBMCs of human blood and stimulated under Th17 
conditions in IMDM (left) or RPMI (right) medium in the absence (top) or 
presence (bottom) of AhR antagonist. IL-17 versus IFN-     intracellular 
staining is shown in the dot plots. The scatter plot shows the percentage 
of IL-17 producers from three different individuals (representing three 
independent experiments) obtained in IMDM versus RPMI medium.     
    Figure 4.         Substitution of RPMI with tryptophan improves Th17 dif-
ferentiation.   (A) Scatter plot showing the percentage of IL-17 producers in 
CD4 T cells from wild-type B6 (fi  lled triangles) or AhR-defi  cient mice (open 
circles) cultured under Th17-polarizing conditions in IMDM (left) or RPMI 
(right) with or without addition of 11 mg/liter of   L-  tryptophan. P values are 
shown in the graph. Data from four independent experiments are shown. 
(B) IL-17/IL-22 expression in CD4 T cells cultured under Th17 conditions in 
either IMDM (left) or RPMI (right) in the absence or presence of AhR agonist 
FICZ after 4 d of culture or (C) in the presence of neutralizing antibodies to 
IFN-     and IL-4. Dot plots are representative of three independent experiments.    JEM VOL. 206, January 19, 2009  47
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IMDM, but even in RPMI medium, antagonizing AhR re-
sulted in a further reduction of Th17 diff  erentiation. In 
contrast to its eff  ect on development of Th17 cells, Th1 po-
larization was not aff  ected by the choice of culture medium 
or the presence of AhR antagonist. The development of iT 
reg cells was even increased in RPMI medium. Human Th17 
cells also express AhR (  3  ), and, similar to mouse T cells, the 
expansion of human Th17 cells from total CD4 T cells in pe-
ripheral blood was markedly better in IMDM compared with 
RPMI medium and strongly reduced in the presence of the 
AhR antagonist (  Fig. 3 B  ). 
  Supplementation of tryptophan partially restores 
Th17 polarization 
  To test whether the increased amount of tryptophan in IMDM 
is involved in the enhanced Th17 polarization in IMDM ver-
sus RPMI medium, we supplemented RPMI medium with 
  l  -tryptophan to adjust levels to those in IMDM. Tryptophan 
supplementation of RPMI signifi  cantly improved Th17 po-
larization, but levels were still much lower than those in 
IMDM. On the other hand, Th17 polarization of AhR-defi  -
cient cells was not infl  uenced by tryptophan (  Fig. 4 A  ).   There 
could be several AhR ligands generated in IMDM, which is 
considerably richer in aromatic amino acids than RPMI. One 
of them may be derived from tryptophan, an essential amino 
acid that functions as the precursor to many substances, in-
cluding melatonin, serotonin, or kynurenic acid. The light 
and culture medium  –  related activation of AhR has been ob-
served as early as 1976 (  20  ). More recently, it was shown that 
the tryptophan metabolite FICZ is produced in culture me-
dium not only under UV irradiation but also under normal 
laboratory light conditions, and is stable during storage in the 
refrigerator for 3 d (  11  ). In this respect, it is notable that the 
other aromatic amino acids that could be metabolic precur-
sors for AhR ligands,   l-  tyrosine and   l-  phenylalanine, are also 
represented in substantially lower amounts in RPMI medium 
(Table S1). Furthermore, it has been suggested that oxidiza-
tion of histidine could also generate an AhR ligand, and this 
amino acid is likewise underrepresented in RPMI compared 
with IMDM (  21  ). However, we found that supplementation 
with these other components did not improve Th17 diff  er-
entiation beyond that seen with tryptophan supplementation 
(unpublished data). Thus, it appears that the relative paucity 
of endogenous AhR ligands only partially explains the defec-
tive Th17 development in RPMI medium. 
  We previously reported that addition of FICZ, a trypto-
phan-derived AhR agonist with high affi   nity, substantially 
increases Th17 polarization and induces IL-22 production 
(  3  ). To test whether FICZ can overcome the defect in Th17 
polarization in RPMI medium, we diff  erentiated naive CD4 
T cells to Th17 in the presence of FICZ. This improved 
    Figure 5.         IL-2 blockade together with AhR activation restored 
Th17 differentiation.   (A) Intracellular IL-17/IL-22 in Th17 cells develop-
ing in IMDM (left) or RPMI medium (right) without (top) or with addition 
of neutralizing antibodies to IL-2 (bottom). Dot plots are representative of 
three independent experiments. (B) Expression of phospho-Stat5 in CD4 T 
cells cultured under Th17 conditions in IMDM (top) or RPMI (bottom) in 
the absence of exogenous AhR agonist (left), with FICZ (middle), or in the 
presence of neutralizing antibodies to IL-2 (right). Histograms (represen-
tative of three independent experiments) of gated CD4 T cells showing 
phospho-Stat5 expression at 48 h after onset of culture are shown. 
(C) IL-17/IL-22 expression in Th17 cells cultured in IMDM (left) or RPMI 
(right) in the presence of neutralizing antibodies to IL-2 and FICZ. Dot plots 
are representative of three independent experiments.     
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onist that is likely to play a role in vivo because exposure of 
human skin to UV-B induces CYP1A1 expression (  23  ), but 
the number and nature of endogenous AhR agonists are still 
a matter of debate (  5  ). Here, we describe that endogenous 
AhR activity present in culture medium has a strong infl  u-
ence on Th17 polarization. Thus, Th17 diff  erentiation repre-
sents an alternative biological system in which the eff  ects of 
potential AhR agonists or antagonists can be directly tested. 
Whereas the assessment of CYP1A1 reporter activity in he-
patocyte or other cell lines, as currently used in the toxicol-
ogy fi   eld, is a reliable and convenient readout for AhR 
activity, the connection of AhR activation to the Th17 pro-
gram opens a wide range of possibilities in regard to testing 
the infl  uence of AhR agonists and antagonists on biological 
processes dependent on these cells. 
  In the immunology fi  eld, obtaining improved Th17 po-
larization in vitro will facilitate their further molecular char-
acterization that depends on methods such as gene array 
analysis or qPCR, which are not reliable unless the popula-
tions analyzed are relatively pure. Furthermore, the analysis 
of human Th17 development, which can only be assessed in 
vitro, will benefi  t from improved culture conditions. Our 
data show that not all media formulations that had been used 
successfully over decades to support the development of CD4 
eff  ector T cell subsets are conducive to Th17 diff  erentiation 
through a combination of lacking AhR agonists and contain-
ing components that interfere with Th17 diff  erentiation. All 
in all, our data emphasize that activation of AhR by a poten-
tially diverse range of endogenous agonists has to be consid-
ered an essential co-factor in the optimal diff  erentiation of 
Th17 eff  ector T cell subset. 
    MATERIALS AND METHODS   
  Mice.     C57BL/6 and B6 BRA AhR KO (AhR-defi  cient B6) mice were bred 
and maintained under specifi  c pathogen  –  free conditions, and all animal ex-
periments were carried out according to institutional guidelines approved by 
the local ethical panel and by a project licence from the UK Home Offi   ce. 
  In vitro T cell diff  erentiation and intracellular staining.     Naive CD4 
T cells were isolated by FACS sorting using a MoFlo sorter of lymph nodes 
cell suspensions for CD44  lo   CD25        CD4  +   cells. The culture mediums used 
were IMDM (Sigma-Aldrich) or RPMI 1640 (Sigma-Aldrich), both supple-
mented with 2   ×   10      3   M   l-  glutamine, 100 U/ml penicillin, 100   μ  g/ml 
streptomycin, 5   ×   10      5   M     -mercaptoethanol, and 5% FCS. In some cases, 
RPMI medium was supplemented with 11 mg/liter   l  -tryptophan (Invitro-
gen) to adjust it to the concentrations found in IMDM. 
  Th17 cells were diff  erentiated on plates coated with 2   μ  g/ml anti-CD3 
+ 5   μ  g/ml anti-CD28 with a cytokine cocktail of 50 ng/ml IL-6, 1 ng/ml 
TGF-    , and 10 ng/ml IL-1. Neutralizing antibodies to IFN-    , IL-4, or IL-2 
were added at 10   μ  g/ml in some experiments. Th1 cells were stimulated in 
the presence of 3 ng/ml IL-12, and iT reg cells were generated by adding 
10 ng/ml TGF-    . The AhR antagonist CH-223191 (Calbiochem) was added 
at 3   μ  M at the start of culture. FICZ was added at 300 nM at the start of 
some cultures. For measurements of intracellular cytokines, T cells were re-
stimulated with 500 ng/ml phorbol dibutyrate and 500 ng/ml ionomycin in 
the presence of brefeldin A for 4 h on day 5 after initiation of cultures. Mea-
surement of Stat5 phosphorylation was done with antibodies to pStat5 (BD) 
according to the manufacturer  ’  s instructions. 
  qPCR analysis.     RNA was extracted using 1-bromo-3-chloro-propane 
(Sigma-Aldrich) and reverse transcribed with oligo d(T)  16   (Applied Biosystems) 
Th17 polarization and, importantly, resulted in some IL-22 
expression. However, similar to tryptophan, supplementation 
of FICZ did not fully restore the defect (  Fig. 4 B  ). 
  IL-2 depletion restores Th17 differentiation, but not IL-22 
production, in RPMI medium 
  Because the diff  erentiation of Th17 cells is strongly inhibited 
by cytokines that support development of the other CD4 T 
cell subsets, we tested whether addition of anti  –  IFN-     and 
  –  IL-4, which are frequently used in Th17 polarization to in-
hibit Th1 and Th2 polarization (  22  ), would have a positive 
infl  uence on generation of this eff  ector T cell subset. How-
ever, blockade of IFN-     and IL-4 had little eff  ect on Th17 
diff  erentiation under our culture conditions (  Fig. 4 C  ). Given 
that our cultures contain highly purifi  ed T cells without APCs, 
this is perhaps not surprising, as blocking IFN-     and IL-4 is 
eff  ective mainly in mixed cultures with insuffi   ciently purifi  ed 
T cells that may contain Th1 or Th2 eff  ector cells and residual 
APCs that may promote Th1 development via secretion of 
IL-12. In contrast, neutralization of IL-2 markedly increased 
Th17 polarization in RPMI medium to levels similar to those 
obtained in IMDM (  Fig. 5 A  ).   In contrast, blockade of IL-2 
had only a marginal eff  ect on Th17 diff  erentiation in IMDM. 
We checked IL-2 production in the two media and could not 
fi  nd a notable diff  erence. Furthermore, careful analysis of IL-2 
mRNA induction and expression of CD25 did not establish 
any diff  erences in the two media (unpublished data). 
  Despite recovery of Th17 diff  erentiation in RPMI by 
blockade of IL-2, this was not suffi   cient to rescue IL-22 ex-
pression. However, IL-22 production in RPMI medium was 
obtained by a combination of IL-2 neutralization and AhR 
ligation, emphasizing the important role for AhR activation 
in induction of IL-22 production (  Fig. 5 C  ). 
  It has been shown that Th17 diff  erentiation is inhibited by 
IL-2 signaling via induction of   Stat5   (  10  ). In line with these 
fi  ndings, we observed considerably more Stat5 phosphoryla-
tion during Th17 culture in RPMI medium (80.5%) com-
pared with IMDM (54.3%), whereas blockade of IL-2 reduced 
Stat5 phosphorylation and the addition of FICZ caused a re-
duction in Stat5 phosphorylation, albeit less dramatic than that 
seen with anti  –  IL-2 (  Fig. 5 B  ). It is currently unknown how 
AhR interacts with the Th17 program. We have shown that 
there is no direct interaction between AhR and ROR    t 
(  Fig. 2  ), but it is conceivable that AhR interacts with other 
transcription factors that positively or negatively infl  uence 
Th17 diff  erentiation. The latter is in agreement with data by 
Kimura et al. (  17  ) showing direct interaction of AhR with 
Stat1 and Stat5 protein. Nevertheless, the interactions between 
IL-2, AhR, and Stat5 are yet to be defi  ned on a molecular level. 
  Collectively, Th17 development is clearly controlled not 
only by multiple cytokines, but also by modulation via acti-
vation of the AhR, whose involvement in shaping Th17 
differentiation in vivo is highlighted by the phenotype of 
AhR-defi  cient mice that show decreased IL-17 development 
and absence of IL-22 production (  3  ). The tryptophan metab-
olite FICZ has been suggested to be an endogenous AhR ag-JEM VOL. 206, January 19, 2009  49
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according to the manufacturer  ’  s protocol. The cDNA served as template for 
the amplifi  cation of genes of interest and the housekeeping gene (Hprt) by 
real-time PCR, using TaqMan Gene Expression Assays and Applied Biosys-
tems 7900HT Fast Real-Time PCR System. The primers obtained from 
Applied Biosystems are as follows: Hprt, Mm00446968_m1; AhR, 
Mm00478930_ml; IL-17A, Mm00439619_m1; IL-22, Mm00444241_m1; 
CYP1A1, Mm00487217_m1. 
  Human Th17 polarization.     CD4 T cells from PBMCs were purifi  ed by 
magnetic cell sorting and cultured on plates coated with 1   μ  g/ml anti-CD3 
and 2.5   μ  g/ml anti-CD28 in either IMDM or RPMI supplemented with 
10% serum replacement factor (Invitrogen) in the presence of 0.5 ng/ml 
TGF-    , 30 ng/ml IL-6, 10 ng/ml IL-1    , and 10 ng/ml IL-23. 
  Statistics.     P values were determined using two-tailed Student  ’  s   t   test. 
  Online supplemental material.     Table S1 is a comparison of the amino 
acid content in IMDM and RPMI. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20081438/DC1. 
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